Statement by Dr. Paul Zeitz, Executive Director, Global AIDS Alliance, Washington, DC on President Obama's Global Health Funding for FY10 as Released by the White House Tuesday, M... ( WASHINGTON May 5 -- The following is...)

HOME >> MEDICINE >> NEWS

Statement by Dr. Paul Zeitz, Executive Director, Global AIDS Alliance, Washington, DC on President Obama's Global Health Funding for FY10 as Released by the White House Tuesday, May 5, 2009

Date:5/5/2009

WASHINGTON, May 5 /PRNewswire-USNewswire/ -- The following is a statement by Dr. Paul Zeitz, Executive Director, Global AIDS Alliance, Washington, DC on President Obama's global health funding for FY10 as released by the White House, Tuesday, May 5, 2009:

"We are disappointed by the preliminary global health budget for FY10 released today at the White House during a special briefing for members of the global health advocacy community, including the Global AIDS Alliance.

"Our analysis of the information provided by the White House today shows that the President's FY10 global health budget essentially flat-lines support for global health, and ignores the President's campaign promises to fully fund PEPFAR and to provide a fair-share contribution to the Global Fund to Fight AIDS, TB, and Malaria.

"Until we see the full budget with line item detail on U.S. bilateral AIDS programs and on the Global Fund we will not know just how far off the mark the budget information presented today really is. In fact, early release of less than completely detailed budget information on the President's global health strategy makes it difficult to know what the real dollars are and how the White House intends on spending them."

SOURCE Global AIDS Alliance
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/5/2013)... Green Tomato Foods, home of Susan's All ... the holidays on all orders of 4 or more jars. ... Ginger Teriyaki Sauce with each order. These uniquely ... or sodium, are low in sugar, gluten free, and high ... created from an old family recipe using fresh green tomatoes ...

(Date:12/5/2013)... 05, 2013 Larvie Learns a Lesson (AuthorHouse ... a lovable caterpillar named Larvie who watches too much television ... for Larvie to spin a cocoon to become a butterfly, ... become the beautiful creature he is meant to be. , ... his friends, Larvie embarks on a new regimen of regular ...

(Date:12/5/2013)... copies during cell division. This process occurs at ... enzymes and move along the separated DNA strands. ... damaged, giving rise to breaks in the double-stranded ... Professor at the Faculty of Sciences at the ... cells repair the damaged replication forks in order ...

(Date:12/5/2013)... 2013 Under-cover vegetables are cultivated ... on weather conditions and seasonal changes than field-grown ... case of greenhouses, generates greater yield output and ... of the industry over the past five years. ... and energy savings, which has also benefited the ...

(Date:12/5/2013)... London (PRWEB) December 05, 2013 Venous ... 2013 , Summary , GlobalData's clinical trial report, “Venous ... 2013" provides data on the Venous Leg Ulcers (Crural ... and data relating to the clinical trials on Venous ... the trial numbers and their recruitment status as per ...

[0] Green Tomato Foods, Inc., Home Of Susan's All Natural Gourmet Salsas, Announces "Zero Shipping" for The Holiday's With An Order Of 4 Or More Jars Of Your Favorite Salsa [0] New Children’s Book Teaches Children About Importance of Healthy Eating Habits Starting at a Young Age [0] Malignant cells adopt a different pathway for genome duplication [0] Under Cover Vegetable Growing in Australia Industry Market Research Report Now Updated by IBISWorld [0] Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013

... a predictor of overall survival benefit with EGFRI treatmentBROOMFIELD, ... proteomic test currently used for patients with advanced stage ... Chung, MD, Assistant Professor of Medicine at Vanderbilt ... Annual Meeting of the American Society of Clinical Oncology ...

... Landmark Validation Trial Highlighted Today at American Society ... Launch Oncotype DX Colon Cancer Test in Early ... Inc. (Nasdaq: GHDX ) today announced ... which demonstrated that the Onco type DX(R) ...

... MedServe, Inc., a private company, today announced that it ... Stericycle, Inc. (Nasdaq: SRCL ) for $185 ... Avista Capital Partners, Chrysalis Ventures and Murphree Venture Partners ... collection, transportation, treatment and disposal of medical waste, hazardous ...

... ChildrenHARRISBURG, Pa., May 14 National dental insurer, United ... forces to help children by offering services at a ... is for students in kindergarten through third grade in ... area dentists will be on hand to provide the ...

... the FDA,s approval of Prevacid OTC(R) 24HR, The Procter ... http://www.newscom.com/cgi-bin/prnh//NY17325 )"Prilosec OTC(R) ... remedy in the U.S.," said Tim Brown - General ... Gamble built the OTC PPI market and since 2003, ...

... system extends PreXion3D image scans to network workstationsSAN ... www.Prexion.com ), a leader in dental ... of DataServer/PX, a DICOM-conformant, massive storage system for ... has accumulated over time through the use of ...

Cached Medicine News:Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 2 Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 3 Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 2 Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 3 Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 4 Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 5 Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 6 Health News:MedServe to be Acquired by Stericycle for $185 Million 2 Health News:MedServe to be Acquired by Stericycle for $185 Million 3 Health News:P&G Response to FDA Approval of Prevacid OTC(R) 24HR 2 Health News:PreXion Adds a Fast, High-Volume Data Storage and Archiving System for Use With Its PreXion3D CBCT X-ray System 2

May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients MedServe to be Acquired by Stericycle for $185 Million United Concordia and Texas Oral Health Coalition Partner to Offer Free Dental Services P&G Response to FDA Approval of Prevacid OTC(R) 24HR PreXion Adds a Fast, High-Volume Data Storage and Archiving System for Use With Its PreXion3D CBCT X-ray System

(Date:12/5/2013)... , Dec. 5, 2013 Aspira ... for the chemical and biological sectors, today announces ... Albumin (rHSA) product. Aspira Scientific,s highly pure, cost-effective ... platform, originating from rice grains ( Oryza sativa ... of any animal, human, or micro-organism derived components ...

(Date:12/5/2013)... Howard Leonhardt of Leonhardt Ventures and ... at the 2013 World Stem Cell Summit on Friday, December ... San Diego in two sessions. 2pm ... 3pm Harbor Room DE - Startup Considerations for ... Cal-X Stars Business Accelerator, Inc. is an innovation accelerator with ...

(Date:12/5/2013)... EarlySense, the market leader in Proactive Patient Care ... Event that the company will be introducing several new ... significant feature is a Patient Rest Indicator which will ... and motion while in bed. This will become an ... out of bed during the night, opposed to existing ...

Breaking Medicine Technology:Aspira Scientific Introduces Xeno-free rHSA Product at World Stem Cell Summit 2 Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th 2 Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th 3 Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th 4 Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th 5 Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th 6 Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th 7 EarlySense Announces Patient Rest Indicator for Better Patient Supervision at Night 2 EarlySense Announces Patient Rest Indicator for Better Patient Supervision at Night 3

[0] Aspira Scientific Introduces Xeno-free rHSA Product at World Stem Cell Summit [0] Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th [0] EarlySense Announces Patient Rest Indicator for Better Patient Supervision at Night

... SAN FRANCISCO, Calif., June 2 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... a,conference call with simultaneous webcast to discuss the preliminary,results ... novel, oral Syk kinase,inhibitor, in patients with B-cell non-Hodgkin,s ... Participating on the call will be Rigel senior,management and ...

... the Federation of Clinical Immunology Societies opens,June 5, ... scientists,and clinicians will convene to present new advances ... the 8th annual meeting of,the Federation of Clinical ... Copley Place., Conference participants will present new ...

Cached Medicine Technology:Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2 Leading Immunologists Convene in Boston 2

Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma Leading Immunologists Convene in Boston

... DUOVISC Viscoelastic System is designed to ... properties that can be used differently and ... cataract procedure. The choice of the viscoelastic ... differential ability of each to facilitate performance ...

... fundus imaging and documentation of the ... need for eyepieces guarantees the fast ... and display is an entirely electronic ... principle of modern fundus cameras. ,Due ...

... Evaluating pupil response and eye movement is ... exams. Thats because eye movements and pupil ... set of visual neuronal centers and pathways ... The VisPath Analyzer (VPA) provides pre-programmed visual ...

... DigiCat Imager ("DCI") to provide rapid, simple, ... DCI can measure the cataract and track ... appropriate and timely surgical decision can be ... is especially useful in todays healthcare environment, ...

Medicine Products:

DuoVisc VISUCAM Digital Camera VisPath Analyzer (VPA)DigiCat Imager